Respiratory Care Market Poised to Hit $36.7 Billion by 2031

This growth is underpinned by a significant global disease burden, headlined by COPD and asthma, which affect over half a billion people worldwide. As populations age and the prevalence of sleep apnea rises, manufacturers are pivoting toward non-invasive and portable technologies. Key drivers include the adoption of connected CPAP and BiPAP systems, which allow clinicians to monitor patient adherence and device performance remotely through cloud-based platforms like ResMed’s AirSense 11.

Beyond technological innovation, structural gaps in healthcare infrastructure are fueling demand. In many emerging markets, particularly across the Asia-Pacific region, the lack of reliable medical oxygen access is incentivizing investment in oxygen concentrators and delivery systems. While North America remains the largest market due to high healthcare spending and established home-care networks, Asia-Pacific is emerging as the fastest-growing territory. Companies like Nihon Kohden, Masimo, and Drägerwerk are responding with AI-enhanced monitoring and adaptive ventilation solutions to capture this expanding patient base, though high costs and patient adherence remain persistent operational hurdles.